超声造影作为肝细胞癌无创诊断流程中二线诊断方式的作用
该前瞻性研究纳入103例有肝细胞癌风险的103个肝脏病灶,评估超声造影(CEUS)在钆塞酸二钠增强MRI(Gd-EOB-MRI)之后作为二线诊断方式对肝细胞癌的诊断效能。CEUS特异度为100%,在Gd-EOB-MRI结果不确定的病灶中加做CEUS可提高肝细胞癌诊断率而不改变特异度。
要点
- CEUS诊断肝细胞癌的敏感度(60.8%)低于Gd-EOB-MRI(72.2%或86.1%),但特异度为100%。
- Gd-EOB-MRI结果不确定时加做CEUS可提高肝细胞癌诊断率:EASL标准下敏感度72.2%对83.5%,KLCA-NCC标准下86.1%对91.1%。
- 在Gd-EOB-MRI上无动脉期高增强的10个肝细胞癌中,8个在CEUS上出现动脉期高增强;无廓清的12个中,8个在CEUS上出现特征性廓清。
临床应用与阅片要点
- CEUS诊断肝细胞癌的敏感度为60.8%,低于Gd-EOB-MRI(EASL标准下72.2%,p=0.06;KLCA-NCC标准下86.1%,p<0.01),但CEUS特异度为100%。
- 在Gd-EOB-MRI结果不确定的病灶中加做CEUS,更多肝细胞癌被诊断:EASL标准下敏感度72.2%对83.5%(p<0.01),KLCA-NCC标准下86.1%对91.1%(p=0.04)。
- Gd-EOB-MRI上无动脉期高增强的10个肝细胞癌中,8个(80.0%)在CEUS上出现动脉期高增强;无廓清的12个中,8个(66.7%)在CEUS上出现特征性廓清。
- CEUS未出现肝细胞癌假阳性病例。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate the diagnostic performance of contrast-enhanced ultrasound (CEUS) and its role as a second-line imaging modality after gadoxetate-enhanced MRI (Gd-EOB-MRI) in the diagnosis of hepatocellular carcinoma (HCC) among at risk observations.
MATERIALS AND METHODS: We prospectively enrolled participants at risk of HCC with treatment-naïve solid hepatic observations (≥ 1 cm) of Liver Imaging Reporting and Data System (LR)-3/4/5/M during surveillance and performed Gd-EOB-MRI. A total of one hundred and three participants with 103 hepatic observations (mean size, 28.2 ± 24.5 mm; HCCs [n = 79], non-HCC malignancies [n = 15], benign [n = 9]; diagnosed by pathology [n = 57], or noninvasive method [n = 46]) were included in this study. The participants underwent CEUS with sulfur hexafluoride. Arterial phase hyperenhancement (APHE) and washout on Gd-EOB-MRI and CEUS were evaluated. The distinctive washout in CEUS was defined as mild washout 60 seconds after contrast injection. The diagnostic ability of Gd-EOB-MRI and of CEUS as a second-line modality for HCC were determined according to the European Association for the Study of the Liver (EASL) and the Korean Liver Cancer Association and National Cancer Center (KLCA-NCC) guidelines. The diagnostic abilities of both imaging modalities were compared using the McNemar's test.
RESULTS: The sensitivity of CEUS (60.8%) was lower than that of Gd-EOB-MRI (72.2%, p = 0.06 by EASL; 86.1%, p < 0.01 by KLCA-NCC); however, the specificity was 100%. By performing CEUS on the inconclusive observations in Gd-EOB-MRI, HCCs without APHE (n = 10) or washout (n = 12) on Gd-EOB-MRI further presented APHE (80.0%, 8/10) or distinctive washout (66.7%, 8/12) on CEUS, and more HCCs were diagnosed than with Gd-EOB-MRI alone (sensitivity: 72.2% vs. 83.5% by EASL, p < 0.01; 86.1% vs. 91.1% by KCLA-NCC, p = 0.04). There were no false-positive cases for HCC on CEUS.
CONCLUSION: The addition of CEUS to Gd-EOB-MRI as a second-line diagnostic modality increases the frequency of HCC diagnosis without changing the specificities.
引用
- Kang HJ, Lee JM, Yoon JH, et al. Role of Contrast-Enhanced Ultrasound as a Second-Line Diagnostic Modality in Noninvasive Diagnostic Algorithms for Hepatocellular Carcinoma. Korean J Radiol. 2020. PMID: 33236540. doi:10.3348/kjr.2020.0973
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。